Stock research firms currently have a positive stance on shares of Arbutus Biopharma Corporation (NASDAQ:ABUS). Analysts are projecting that the stock will reach $7.44 on a short term (1 year) basis.
The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.80. This is based on the research brokerage reports taken into consideration by Thomson Reuters.
At the time of writing, the stock was trading at $5.00. This represents a change from most recent open price of 2.04%. In terms of performance, year to date, the stock is 104.08%. The monthly stock performance comes in at 35.14%. For the quarter, shares are performing at 38.89%. Weekly performance analysis shows the equity at 6.38%.
In taking a look at technical levels, shares are trading 29.23% away from the 50 day simple moving average and 53.23% away from the 200 day simple moving average. Based on a recent bid, the stock is trading 4.17% away from it’s 52- week high and 112.77% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Arbutus Biopharma Corporation’s RSI stands at 72.47. In looking at volatility levels, the shares saw weekly volatility of 5.91% and 4.72% over the past month.
Brokerage firms currently have a positive stance on shares of Connecture, Inc. (NASDAQ:CNXR). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.30. Those same analysts are projecting that the stock will reach $2.75 on a short term basis.
Connecture, Inc. (NASDAQ:CNXR) shares typically trade an average volume of 113.04 and institutions hold 57.30% of the total shares.
We see here that the stock is 13.34% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of 10.82% from current levels. Further back, their 200-Day Simple Moving Average is -35.04% difference from today’s price. Currently, the stock is -27.69% from its 50-Day High and 61.79% from the 50-day low.
Connecture, Inc. (NASDAQ:CNXR)‘s stock has performed at -53.57%. Breaking that down further, it has performed 9.84% for the week, 9.86% for the month, -4.88% over the last quarter, -43.07% for the past half-year and -55.93% for this last year.